OSH STATE UNIVERSITY
International Medical Faculty
Department of Pediatrics (Child Diseases)
Diseases of the Gallbladder and Biliary Tract in Children: Biliary Tract Dyskinesia, Cholecystitis, and Developmental Abnormalities
An Academic Review Article for Pediatrics (Child Diseases)
Authors:
Anjali Yadav | Mohammad Mohamed
Email: ay813983@gmail.com
University: Osh State University, IMF
Year: 2026
Abstract
Diseases of the gallbladder and biliary tract constitute a clinically significant subset of pediatric gastrointestinal disorders. While historically considered rare in childhood, advances in diagnostic ultrasonography and growing awareness have revealed a rising prevalence of biliary pathologies in pediatric populations. This article provides a comprehensive academic review of three major categories: biliary tract dyskinesia, cholecystitis, and developmental abnormalities of the gallbladder and biliary tree. Biliary tract dyskinesia, characterized by impaired motility of the biliary system, is increasingly recognized as a cause of recurrent abdominal pain in children. Cholecystitis, encompassing both calculous and acalculous forms, presents with variable clinical features that mandate timely recognition and intervention. Developmental abnormalities such as biliary atresia, choledochal cysts, and gallbladder agenesis, though less common, carry profound implications for neonatal and pediatric health. This review discusses the etiology, pathophysiology, clinical manifestations, diagnostic workup, and current management strategies for each condition, drawing on standard pediatric references including Ghai Essential Pediatrics, Nelson Textbook of Pediatrics, and IAP Textbook of Pediatrics. Early diagnosis and appropriate multidisciplinary management are essential for optimizing outcomes and preventing long-term hepatobiliary complications.
Keywords: Biliary tract dyskinesia, cholecystitis, biliary atresia, choledochal cyst, pediatric hepatobiliary disease, gallbladder disorders in children.
1. Introduction
Gallbladder and biliary tract diseases, though frequently perceived as adult conditions, are increasingly documented in pediatric practice. With the widespread availability of abdominal ultrasonography, clinicians now identify biliary pathologies in neonates, infants, and older children with greater frequency. The spectrum of these disorders ranges from functional abnormalities such as biliary tract dyskinesia to inflammatory conditions like cholecystitis and structural anomalies including biliary atresia and choledochal cysts.
In children, the clinical presentation of biliary diseases often differs substantially from adults, making diagnosis challenging. Symptoms such as recurrent abdominal pain, jaundice, nausea, and vomiting can be nonspecific and may overlap with numerous other gastrointestinal and systemic conditions. This necessitates a thorough understanding of the unique anatomical, physiological, and developmental aspects of the pediatric biliary system.
The importance of early and accurate diagnosis cannot be overstated. Delayed recognition of conditions such as biliary atresia can result in irreversible cirrhosis, while untreated cholecystitis may lead to perforation, peritonitis, and sepsis. Similarly, undiagnosed choledochal cysts carry a risk of malignant transformation over time. Comprehensive knowledge of these conditions is therefore fundamental for medical students and clinicians involved in pediatric care.
This article aims to provide medical students with a structured and academically rigorous overview of the major gallbladder and biliary tract diseases in children, with particular emphasis on biliary tract dyskinesia, cholecystitis, and developmental abnormalities, in alignment with standard MBBS pediatrics curricula.
2. Anatomy and Physiology of the Gallbladder and Biliary Tract
The biliary system is a network of ducts responsible for the production, transport, and delivery of bile from the liver to the duodenum. In children, as in adults, bile is synthesized by hepatocytes and secreted into bile canaliculi, which coalesce to form intrahepatic bile ducts. These progressively join to form the right and left hepatic ducts, which merge at the porta hepatis to form the common hepatic duct.
The gallbladder is a pear-shaped hollow viscus located in the gallbladder fossa on the inferior surface of the right hepatic lobe. It serves as a reservoir for bile, which is concentrated and stored between meals. The cystic duct connects the gallbladder to the common hepatic duct to form the common bile duct (CBD), which descends through the hepatoduodenal ligament, passes behind the duodenum and through the head of the pancreas, and opens into the second part of the duodenum at the ampulla of Vater, regulated by the sphincter of Oddi.
In neonates, the biliary system is structurally complete but functionally immature. Bile salt synthesis is reduced, which impairs fat absorption. As the child matures, bile composition evolves toward the adult pattern. The gallbladder in infants is relatively larger in proportion to body size. Contraction of the gallbladder is triggered primarily by cholecystokinin (CCK), released from duodenal mucosa in response to fat and protein ingestion.
Physiologically, bile serves critical roles in lipid emulsification and absorption of fat-soluble vitamins (A, D, E, and K). Disruption of bile flow, whether due to structural obstruction, dysmotility, or inflammation, can impair these processes and result in steatorrhea, fat-soluble vitamin deficiencies, and cholestasis.
3. Biliary Tract Dyskinesia in Children
3.1 Definition
Biliary tract dyskinesia (BTD) refers to a functional disorder of the biliary system characterized by impaired contractility of the gallbladder or abnormal tone of the sphincter of Oddi, in the absence of structural pathology such as gallstones. It is broadly classified into two types: gallbladder dyskinesia (involving impaired emptying of the gallbladder) and sphincter of Oddi dysfunction (involving increased resistance at the sphincter level).
3.2 Etiology
The exact etiology of biliary dyskinesia in children remains incompletely understood. Proposed contributing factors include:
• Abnormal neural regulation of gallbladder smooth muscle by the enteric nervous system
• Altered hormonal signaling, particularly reduced sensitivity to cholecystokinin (CCK)
• Post-infectious disruption of gallbladder motility following viral or bacterial gastroenteritis
• Association with functional gastrointestinal disorders such as irritable bowel syndrome
• Psychosocial stressors in school-age children and adolescents
3.3 Pathophysiology
In gallbladder dyskinesia, reduced gallbladder ejection fraction leads to bile stasis and increased luminal pressure during attempted contraction. This results in episodic biliary colic-type pain. Chronic bile stasis may predispose to gallstone formation over time. Sphincter of Oddi dysfunction, on the other hand, involves biliary hypertension proximal to a hypercontractile or stenotic sphincter, leading to recurrent pain and, in some cases, elevated liver enzymes or bile duct dilation.
3.4 Clinical Features
Children with biliary dyskinesia typically present with recurrent episodes of right upper quadrant or epigastric pain, often postprandial. Associated symptoms may include nausea, vomiting, anorexia, and intolerance to fatty foods. Physical examination may be unremarkable between episodes, with mild right upper quadrant tenderness during acute episodes. The absence of fever and leukocytosis distinguishes it from inflammatory biliary conditions.
3.5 Diagnostic Methods
Diagnosis is primarily established through hepatobiliary iminodiacetic acid (HIDA) scintigraphy with CCK stimulation, which measures the gallbladder ejection fraction (GBEF). A GBEF of less than 35-40% is considered abnormal and indicative of gallbladder dyskinesia. Abdominal ultrasound is performed to exclude structural pathology such as gallstones or biliary dilation. Laboratory investigations including liver function tests, amylase, and lipase are generally normal.
3.6 Treatment and Management
Initial management involves dietary modifications, including reduction of fatty and spicy foods, and analgesics for pain relief. In children with confirmed low GBEF and significant functional impairment despite conservative measures, laparoscopic cholecystectomy has demonstrated symptomatic improvement in carefully selected cases. The decision for surgery should be made cautiously in pediatric patients given the functional nature of the disorder and the possibility of spontaneous resolution.
4. Cholecystitis in Children
4.1 Definition
Cholecystitis refers to inflammation of the gallbladder. In the pediatric population, it is classified into acute and chronic forms, and further subdivided based on the presence or absence of gallstones as calculous and acalculous cholecystitis, respectively.
4.2 Causes
4.2.1 Calculous Cholecystitis
Calculous cholecystitis occurs secondary to gallstone (cholelithiasis) disease. In children, risk factors for gallstone formation include:
• Hemolytic anemias: sickle cell disease, hereditary spherocytosis, beta-thalassemia major
• Obesity and metabolic syndrome, increasingly prevalent in adolescents
• Prolonged total parenteral nutrition (TPN) in neonates and critically ill infants
• Ileal disease or resection, as seen in Crohn disease, impairing bile salt reabsorption
• Cystic fibrosis, associated with abnormal bile composition
• Family history of gallstone disease
4.2.2 Acalculous Cholecystitis
Acalculous cholecystitis, occurring without gallstones, accounts for a significant proportion of cholecystitis in hospitalized children. Predisposing factors include prolonged fasting, sepsis, major trauma or surgery, burns, and immunosuppression. Bile stasis and ischemia of the gallbladder wall are central to its pathogenesis.
4.3 Clinical Manifestations
Children with acute cholecystitis typically present with:
• Sudden onset right upper quadrant or epigastric pain, often radiating to the right shoulder or scapula
• Fever with chills, particularly in bacterial cholecystitis or superimposed cholangitis
• Nausea, vomiting, and anorexia
• Murphy sign: inspiratory arrest on palpation of the right upper quadrant (positive in acute cholecystitis)
• Jaundice, when associated with common bile duct obstruction
Chronic cholecystitis presents with a more indolent course of recurrent biliary colic, bloating, and fat intolerance.
4.4 Laboratory Findings
| Investigation | Expected Finding in Cholecystitis |
| Complete Blood Count (CBC) | Leukocytosis with neutrophilia; anemia if underlying hemolytic disease |
| Liver Function Tests (LFTs) | Elevated AST, ALT, ALP, and GGT; raised bilirubin in obstructive cases |
| Serum Amylase/Lipase | May be elevated if associated pancreatitis is present |
| C-Reactive Protein (CRP) | Markedly elevated, indicating systemic inflammation |
| Blood Culture | Positive in bacterial cholangitis; common organisms: E. coli, Klebsiella, Enterococcus |
| Urine Analysis | Bilirubinuria if conjugated hyperbilirubinemia is present |
4.5 Imaging Investigations
Abdominal ultrasonography is the primary and most accessible imaging modality for diagnosing cholecystitis. It demonstrates gallbladder wall thickening (greater than 3.5 mm), pericholecystic fluid, gallstones with acoustic shadowing, and a sonographic Murphy sign. HIDA scintigraphy can confirm acute cholecystitis when ultrasound findings are equivocal by demonstrating non-visualization of the gallbladder. CT scan of the abdomen may be indicated in complicated cases to assess for perforation, abscess formation, or associated biliary dilation.
4.6 Complications
• Gangrenous cholecystitis with gallbladder necrosis
• Gallbladder perforation leading to bile peritonitis or pericholecystic abscess
• Ascending cholangitis with risk of septicemia
• Gallstone ileus in older adolescents (rare)
• Pancreatitis secondary to common bile duct stones
4.7 Treatment and Management
Management of acute cholecystitis includes initial conservative therapy with intravenous fluids, nil per oral (NPO) status, analgesics, and broad-spectrum antibiotics (such as third-generation cephalosporins or piperacillin-tazobactam). Definitive treatment is laparoscopic cholecystectomy, which is the gold standard for calculous cholecystitis. The timing of surgery may be early (within 72 hours) or interval (after 6 weeks) depending on the clinical condition and local expertise. In acalculous cholecystitis, addressing the underlying precipitating condition is paramount, with cholecystostomy or cholecystectomy reserved for refractory or complicated cases.
5. Developmental Abnormalities of the Gallbladder and Biliary Tract
5.1 Biliary Atresia
Biliary atresia (BA) is a progressive fibroinflammatory obliteration of the extrahepatic bile ducts, presenting in the neonatal period as conjugated hyperbilirubinemia and cholestasis. It is the most common cause of chronic liver disease and liver transplantation in children. The incidence is approximately 1 in 10,000 to 15,000 live births. The etiopathogenesis is multifactorial, involving an abnormal immune-mediated inflammatory response, possibly triggered by viral agents such as rotavirus or cytomegalovirus, in a genetically predisposed host.
Clinical features include persistent jaundice beyond the physiological period (beyond 14 days in term neonates), acholic (pale/clay-colored) stools, dark urine, and hepatomegaly. The Kasai portoenterostomy (hepatic portoenterostomy) is the primary surgical intervention, which should ideally be performed before 60 days of age to achieve bile drainage and retard hepatic fibrosis. Despite early surgery, a significant proportion of children ultimately require liver transplantation.
5.2 Gallbladder Agenesis
Agenesis of the gallbladder is a rare congenital anomaly occurring when the gallbladder primordium fails to develop during embryogenesis. It may be isolated or associated with other congenital anomalies including cardiac defects, vertebral anomalies, and intestinal malrotation. Many cases are asymptomatic and discovered incidentally on imaging. However, some patients may present with biliary colic due to bile duct distension. Diagnosis is confirmed by abdominal ultrasound and MRCP (Magnetic Resonance Cholangiopancreatography). Treatment is generally conservative unless biliary symptoms warrant surgical exploration.
5.3 Choledochal Cyst
Choledochal cysts are congenital cystic dilations of the biliary ductal system and are classified according to the Todani classification system into five types (I through V), with Type I (fusiform dilation of the common bile duct) being most common. The anomalous pancreaticobiliary junction (APBJ), wherein the pancreatic duct joins the common bile duct outside the duodenal wall, is a strongly associated pathophysiological mechanism, allowing reflux of pancreatic enzymes into the biliary tree.
Clinical presentation varies by age. In neonates and infants, the classic triad of jaundice, palpable abdominal mass, and abdominal pain is observed, though complete triad presentation is uncommon. In older children and adolescents, recurrent abdominal pain, cholangitis, and pancreatitis are more typical. Diagnosis is established by ultrasound, followed by MRCP or endoscopic retrograde cholangiopancreatography (ERCP) for anatomical delineation. Complete surgical excision of the cyst with Roux-en-Y hepaticojejunostomy is the treatment of choice, given the risk of malignant transformation (cholangiocarcinoma) if left untreated.
5.4 Other Congenital Anomalies
Additional developmental anomalies include the following:
• Gallbladder duplication: Presence of two separate gallbladders with distinct cystic ducts, most often incidental
• Ectopic gallbladder: Abnormal positioning including intrahepatic, left-sided, or retrodisplaced gallbladder
• Biliary duct anomalies: Aberrant right hepatic duct, low insertion of the cystic duct, or accessory bile ducts
• Caroli disease: Segmental, non-obstructive dilation of the intrahepatic bile ducts, associated with congenital hepatic fibrosis and risk of cholangiocarcinoma
6. Diagnostic Approaches
6.1 Laboratory Investigations
Baseline investigations for suspected biliary pathology include a complete blood count, liver function tests (total and direct bilirubin, AST, ALT, ALP, GGT), serum amylase and lipase, coagulation profile, and inflammatory markers (CRP, ESR). In neonates with suspected biliary atresia, a split bilirubin profile is essential to confirm conjugated hyperbilirubinemia.
6.2 Ultrasonography
Abdominal ultrasound remains the first-line imaging modality due to its wide availability, lack of ionizing radiation, and reliability in detecting gallstones, biliary dilation, gallbladder wall changes, and gross structural anomalies. It has a high sensitivity for cholelithiasis (greater than 95%) and acute cholecystitis.
6.3 Other Imaging Techniques
| Modality | Indication | Key Features |
| HIDA Scintigraphy | Biliary dyskinesia, biliary atresia | Measures GBEF; non-visualization in biliary atresia |
| MRCP | Choledochal cyst, biliary atresia, ductal anomalies | Non-invasive; excellent bile duct visualization |
| ERCP | Therapeutic biliary intervention, stone removal | Invasive; used selectively in children |
| CT Abdomen | Complicated cholecystitis, neoplastic evaluation | Detailed anatomy; radiation concern in children |
| Liver Biopsy | Biliary atresia, metabolic liver disease | Histopathological confirmation of biliary disease |
7. Complications
Untreated or inadequately managed biliary tract diseases in children may lead to a range of significant complications:
• Cirrhosis and portal hypertension: Consequent to progressive hepatic fibrosis as seen in biliary atresia and Caroli disease
• Cholangitis: Bacterial ascent through the biliary tree resulting in fever, jaundice, and right upper quadrant pain (Charcot triad)
• Gallbladder perforation: A surgical emergency with risk of bile peritonitis
• Biliary pancreatitis: Triggered by common bile duct calculi or choledochal cyst with pancreatic reflux
• Malignant transformation: Long-standing choledochal cysts and sclerosing cholangitis carry risk of cholangiocarcinoma
• Liver failure: End-stage consequence of untreated biliary atresia, necessitating transplantation
8. Differential Diagnosis
Given the nonspecific nature of symptoms in pediatric biliary disease, a broad differential diagnosis should be considered:
| Symptom | Key Differentials |
| Neonatal jaundice with cholestasis | Biliary atresia, neonatal hepatitis, Alagille syndrome, alpha-1-antitrypsin deficiency |
| Recurrent abdominal pain in children | Biliary dyskinesia, peptic ulcer disease, functional abdominal pain, appendicitis, constipation |
| Right upper quadrant pain with fever | Cholecystitis, liver abscess, hepatitis, right lower lobe pneumonia |
| Abdominal mass in infant | Choledochal cyst, hepatoblastoma, Wilms tumor, mesenteric cyst |
| Conjugated hyperbilirubinemia | Biliary atresia, choledochal cyst, inspissated bile syndrome, TPN-associated cholestasis |
9. Treatment and Management
Management of biliary tract diseases in children is tailored to the specific diagnosis, disease severity, and patient age. General principles include:
• Conservative management: Dietary modifications, hydration, analgesics, and antibiotics are the cornerstone of initial management for inflammatory conditions
• Endoscopic interventions: ERCP with sphincterotomy and stone extraction is employed for choledocholithiasis and sphincter of Oddi dysfunction in older children
• Surgical management: Laparoscopic cholecystectomy for symptomatic cholelithiasis and cholecystitis; Kasai portoenterostomy for biliary atresia; cyst excision with biliary reconstruction for choledochal cysts
• Liver transplantation: Reserved for biliary atresia with failed Kasai procedure, end-stage liver disease from Caroli disease, or progressive cirrhosis
• Ursodeoxycholic acid (UDCA): Used in cholestatic conditions to promote bile flow and reduce hepatocyte injury
10. Prevention and Prognosis
Prevention of biliary diseases in children focuses on modifiable risk factors. Obesity management through diet and physical activity reduces the risk of cholelithiasis. Neonates requiring prolonged TPN should receive early enteral feeding when feasible and may benefit from UDCA supplementation to prevent TPN-associated cholestasis. Children with known hemolytic anemias should receive regular monitoring for gallstone formation.
The prognosis of biliary diseases varies considerably by diagnosis. Biliary dyskinesia often improves spontaneously or with dietary adjustments, with good long-term outcomes. Cholecystitis managed with timely cholecystectomy carries an excellent prognosis. Biliary atresia, however, has a more guarded prognosis: approximately 50-60% of patients who undergo Kasai portoenterostomy before 60 days of age achieve adequate bile drainage, though a significant proportion still develop cirrhosis. Liver transplantation offers a 5-year survival rate exceeding 85% in specialized centers. Choledochal cysts have favorable outcomes after complete surgical excision, although vigilance for biliary strictures and long-term surveillance for recurrent cholangitis or malignancy is required.
11. Conclusion
Diseases of the gallbladder and biliary tract in children encompass a wide spectrum of functional, inflammatory, and structural pathologies. Biliary tract dyskinesia, though a functional disorder, significantly impairs quality of life and requires appropriate diagnostic evaluation and management. Cholecystitis, whether calculous or acalculous, demands prompt recognition and treatment to prevent life-threatening complications. Developmental anomalies such as biliary atresia and choledochal cysts are among the most serious biliary conditions in pediatric practice, necessitating early surgical intervention to preserve liver function.
A thorough understanding of these conditions, including their pathophysiology, diagnostic criteria, and management algorithms, is essential for medical students and future clinicians involved in pediatric care. Multidisciplinary collaboration among pediatric gastroenterologists, surgeons, radiologists, and pathologists is critical in achieving optimal outcomes. Continued research into the molecular mechanisms and novel therapeutic options remains imperative for improving the management of these complex conditions in the pediatric population.
References
1. Ghai OP, Paul VK, Bagga A. Ghai Essential Pediatrics. 9th ed. CBS Publishers and Distributors; 2019. Chapter on Gastroenterology and Hepatology.
2. Kliegman RM, St Geme JW, Blum NJ, et al. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2020. Chapter 369: Diseases of the Gallbladder.
3. Parthasarathy A, ed. IAP Textbook of Pediatrics. 6th ed. New Delhi: Jaypee Brothers Medical Publishers; 2016. Section on Pediatric Gastroenterology.
4. Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver Disease in Children. 4th ed. Cambridge University Press; 2014.
5. Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004;39(2):115-128.
6. Pandya S, Heiss K. Biliary dyskinesia in children: a systematic review and meta-analysis. J Pediatr Surg. 2012;47(9):1750-1755.
7. Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin North Am. 1990;70(6):1297-1312.
8. Kasai M. Advances and prospects of hepatic portoenterostomy. Nihon Geka Gakkai Zasshi. 1983;84(12):1489-1495.
9. Todani T, Watanabe Y, Narusue M, Tabuchi K, Okajima K. Congenital bile duct cysts: Classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg. 1977;134(2):263-269.
10. Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 11th ed. Philadelphia: Saunders Elsevier; 2021.